CAPRIN1 and laryngeal carcinoma: Furthermore, cell viability assays demonstrated that the cell viability and colony number of TU-177/R cells were significantly decreased in the treatment of cisplatin (Figures 3(g) and 3(h)), indicating that CAPRIN1 knockdown suppressed cisplatin resistance in laryngeal cancer cells.